Old Articles: <Older 8101-8110 Newer> |
|
The Motley Fool December 2, 2011 Selena Maranjian |
Make Money in Growing Medical Device Stocks the Easy Way If you expect medical devices companies to thrive as our population ages and needs products and procedures such as stents and pacemakers, the iShares Dow Jones US Medical Devices ETF could save you a lot of trouble. |
The Motley Fool December 1, 2011 John Grgurich |
Pfizer Losing Lipitor Patent: What Investors Need to Know The patent ends today. |
The Motley Fool December 1, 2011 David Meier |
Why I Am Buying MAKO Surgical MAKO Surgical is changing orthopedic surgery, one robot at a time. |
The Motley Fool November 30, 2011 David Williamson |
5 Top November Health-Care Stocks These stocks had an amazing month. |
The Motley Fool November 30, 2011 David Williamson |
Health Care's 5 Worst November Flops These stocks had a terrible month. |
The Motley Fool November 30, 2011 Brian Orelli |
Drugmakers Bleeding Out That's not what blood thinners are supposed to do. |
The Motley Fool November 30, 2011 Brian Orelli |
This $581 Doughnut Hole Costs Drugmakers It's costing drugmakers money. Can they recoup it elsewhere? |
The Motley Fool November 30, 2011 Brian Orelli |
In Drug Development, Help Is Crucial Curis announced a partnership with The Leukemia & Lymphoma Society to fund the development of its preclinical compound CUDC-907. |
The Motley Fool November 30, 2011 Brian Orelli |
Up Big With Room to Run Lofty hep C valuations are par for the course. |
Chemistry World November 30, 2011 Patrick Walter |
Autumn windfall for UK science and industry The UK government has announced a raft of measures in its autumn statement to try to boost the flagging economy. There is some good news for the research community, as well as the chemical and life science industries. |
<Older 8101-8110 Newer> Return to current articles. |